miR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia

Jiang X, Huang H, Li Z, He C, Li Y, Chen P, Gurbuxani S, Arnovitz S, Hong GM, Price C, Ren H, Kunjamma RB, Neilly MB, Salat J, Wunderlich M, Slany R, Zhang Y, Larson RA, Le Beau MM, Mulloy JC, Rowley JD, Chen J (2012)

Publication Status: Published

Publication Type: Journal article, Original article

Publication year: 2012

Journal

Proceedings of the National Academy of Sciences of the United States of America National Academy of Sciences

Book Volume: 109

Pages Range: 19397-19402

Journal Issue: 47

DOI: 10.1073/pnas.1217519109

Abstract

Acute myeloid leukemia (AML) is a heterogeneous group of hematopoietic malignancies with variable response to treatment. AMLs bearing MLL (mixed lineage leukemia) rearrangements are associated with intermediate or poor survival. MicroRNAs (miRNAs), a class of small noncoding RNAs, have been postulated to be important gene expression regulators virtually in all biological processes, including leukemogenesis. Through a large-scale, genomewide miRNA expression profiling assay of 85 human AML and 15 normal control samples, we show that among 48 miRNAs that are significantly differentially expressed between MLL- and non-MLL-rearranged AML samples, only one (miR-495) is expressed at a lower level in MLL-rearranged AML than in non-MLL-rearranged AML; meanwhile, miR-495 is also significantly down-regulated in MLL-rearranged AML samples compared with normal control samples. Through in vitro colony-forming/replating assays and in vivo bone marrow transplantation studies, we show that forced expression of miR-495 significantly inhibits MLL-fusion-mediated cell transformation in vitro and leukemogenesis in vivo. In human leukemic cells carrying MLL rearrangements, ectopic expression of miR-495 greatly inhibits cell viability and increases cell apoptosis. Furthermore, our studies demonstrate that PBX3 and MEIS1 are two direct target genes of miR-495, and forced expression of either of them can reverse the effects of miR-495 overexpression on inhibiting cell viability and promoting apoptosis of human MLL-rearranged leukemic cells. Thus, our data indicate that miR-495 likely functions as a tumor suppressor in AML with MLL rearrangements by targeting essential leukemia-related genes.

Authors with CRIS profile

Robert Slany Lehrstuhl für Genetik

Involved external institutions

University of Chicago US United States (USA) (US) University of Cincinnati US United States (USA) (US) Northwestern University US United States (USA) (US)

How to cite

APA:

Jiang, X., Huang, H., Li, Z., He, C., Li, Y., Chen, P.,... Chen, J. (2012). miR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia. Proceedings of the National Academy of Sciences of the United States of America, 109(47), 19397-19402. https://doi.org/10.1073/pnas.1217519109

MLA:

Jiang, Xi, et al. "miR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia." Proceedings of the National Academy of Sciences of the United States of America 109.47 (2012): 19397-19402.

BibTeX: Download